{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:43:15Z","timestamp":1784288595096,"version":"3.55.0"},"reference-count":40,"publisher":"Baishideng Publishing Group Inc.","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2017]]},"DOI":"10.3748\/wjg.v23.i24.4390","type":"journal-article","created":{"date-parts":[[2017,6,26]],"date-time":"2017-06-26T10:21:45Z","timestamp":1498472505000},"page":"4390","source":"Crossref","is-referenced-by-count":8,"title":["Gastric cancer-derived heat shock protein-gp96 peptide complex enhances dendritic cell activation"],"prefix":"10.3748","volume":"23","author":[{"given":"Wen-Wen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Levin D, Constant S, Pasqualini T, Flavell R, Bottomly K. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. J Immunol 1993;151:6742-6750.","DOI":"10.4049\/jimmunol.151.12.6742"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-013-0240-3"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0698"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1068408"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(98)00013-8"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000136876.11928.be"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SA. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst 1993;85:1558-1570.","DOI":"10.1093\/jnci\/85.19.1558"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Srivastava PK, Udono H. Heat shock protein-peptide complexes in cancer immunotherapy. Curr Opin Immunol 1994;6:728-732.","DOI":"10.1016\/0952-7915(94)90076-0"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Udono H, Levey DL, Srivastava PK. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc Natl Acad Sci USA 1994;91:3077-3081.","DOI":"10.1073\/pnas.91.8.3077"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Tamura Y, Peng P, Liu K, Daou M, Srivastava PK. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 1997;278:117-120.","DOI":"10.1126\/science.278.5335.117"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/dna.1994.13.117"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.8.5472"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Zheng H, Dai J, Stoilova D, Li Z. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J Immunol 2001;167:6731-6735.","DOI":"10.4049\/jimmunol.167.12.6731"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199807000-00004"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Rivoltini L, Castelli C, Carrabba M, Mazzaferro V, Pilla L, Huber V, Coppa J, Gallino G, Scheibenbogen C, Squarcina P. Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells. J Immunol 2003;171:3467-3474.","DOI":"10.4049\/jimmunol.171.7.3467"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Hoos A, Levey DL. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications. Expert Rev Vaccines 2003;2:369-379.","DOI":"10.1586\/14760584.2.3.369"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-003-0481-9"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20001015)88"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Meng SD, Song J, Rao Z, Tien P, Gao GF. Three-step purification of gp96 from human liver tumor tissues suitable for isolation of gp96-bound peptides. J Immunol Methods 2002;264:29-35.","DOI":"10.1016\/S0022-1759(02)00093-5"},{"key":"ref20","unstructured":"Dai J, Liu B, Caudill MM, Zheng H, Qiao Y, Podack ER, Li Z. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory. Cancer Immun 2003;3:1."},{"key":"ref21","unstructured":"Zhu KQ, Zhang SJ. Study of Loss of Heterozygosity on Chromosome 9p21-22 in Sporadic Gliomas. Zhejiang Daxue Xuebao 2001;30:87-89."},{"key":"ref22","unstructured":"Tong XM, Jin J, Xue YQ, Wang YG. The study of dendritic cells derived from acute myeloid leukemia cells. Zhonghua Neike Zazhi 2004;43:45-48."},{"key":"ref23","unstructured":"Tong XM, Jin J, Qian WB, Meng HT, Xue YQ. Biological features of dendritic cells derived from chronic myeloid leukemia cells in vitro. Zhejiang Daxue Xuebao 2005;34:348-352, 357."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2007.00986.x"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(96)00078-6"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994;179:1109-1118.","DOI":"10.1084\/jem.179.4.1109"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Shinagawa N, Yamazaki K, Tamura Y, Imai A, Kikuchi E, Yokouchi H, Hommura F, Oizumi S, Nishimura M. Immunotherapy with dendritic cells pulsed with tumor-derived gp96 against murine lung cancer is effective through immune response of CD8+ cytotoxic T lymphocytes and natural killer cells. Cancer Immunol Immunother 2008;57:165-174.","DOI":"10.1007\/s00262-007-0359-3"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939593"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27332"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Srivastava PK, Udono H, Blachere NE, Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 1994;39:93-98.","DOI":"10.1007\/BF00188611"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.100301.064801"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-05-1553"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat Immunol 2004;5:685-692.","DOI":"10.1038\/ni1088"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00178-1"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.1.3.539"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/77835"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00111-X"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Doody AD, Kovalchin JT, Mihalyo MA, Hagymasi AT, Drake CG, Adler AJ. Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function. J Immunol 2004;172:6087-6092.","DOI":"10.4049\/jimmunol.172.10.6087"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"SenGupta D, Norris PJ, Suscovich TJ, Hassan-Zahraee M, Moffett HF, Trocha A, Draenert R, Goulder PJ, Binder RJ, Levey DL. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II. J Immunol 2004;173:1987-1993.","DOI":"10.4049\/jimmunol.173.3.1987"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-05-3905"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v23\/i24\/4390.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:51:33Z","timestamp":1692852693000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v23\/i24\/4390.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":40,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v23.i24.4390","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}